Welcome to NQMC. Skip directly to: Search Box, Navigation, Content.


Complete Summary


TITLE

Management of acute pain: percentage of patients receiving neuraxial blockade as part of their acute pain management who develop an epidural abscess or epidural haematoma following neuraxial blockade, during the time period under study.

SOURCE(S)

  • Australian Council on Healthcare Standards (ACHS). ACHS clinical indicator users' manual 2008. ULTIMO NSW: Australian Council on Healthcare Standards (ACHS); 2007 Dec. 776 p.

Measure Domain

PRIMARY MEASURE DOMAIN

SECONDARY MEASURE DOMAIN

Does not apply to this measure

Brief Abstract

DESCRIPTION

This measure is used to assess the percentage of patients receiving neuraxial blockade as part of their acute pain management who develop an epidural abscess or epidural haematoma following neuraxial blockade, during the time period under study.

RATIONALE

Continuous collection of information regarding 'major adverse events' may allow more accurate estimation of prevalence for rare events over time.

PRIMARY CLINICAL COMPONENT

Management of acute pain; neuraxial blockade; epidural abscess; epidural haematoma

DENOMINATOR DESCRIPTION

Total number of patients receiving neuraxial blockade as part of their acute pain management, during the time period under study

NUMERATOR DESCRIPTION

Total number of patients developing an epidural abscess, or epidural haematoma following neuraxial blockade, during the time period under study

Evidence Supporting the Measure

EVIDENCE SUPPORTING THE CRITERION OF QUALITY

  • A clinical practice guideline or other peer-reviewed synthesis of the clinical evidence
  • A formal consensus procedure involving experts in relevant clinical, methodological, and organizational sciences

Evidence Supporting Need for the Measure

NEED FOR THE MEASURE

Use of this measure to improve performance

EVIDENCE SUPPORTING NEED FOR THE MEASURE

  • Australian Council on Healthcare Standards (ACHS). Australian clinical indicator report 1998-2006. Determining the potential to improve quality of care: 8th edition. ULTIMO NSW: Australian Council on Healthcare Standards (ACHS); 2007. 564 p.

State of Use of the Measure

STATE OF USE

Current routine use

CURRENT USE

Internal quality improvement

Application of Measure in its Current Use

CARE SETTING

Hospitals

PROFESSIONALS RESPONSIBLE FOR HEALTH CARE

Physicians

LOWEST LEVEL OF HEALTH CARE DELIVERY ADDRESSED

Single Health Care Delivery Organizations

TARGET POPULATION AGE

Unspecified

TARGET POPULATION GENDER

Either male or female

STRATIFICATION BY VULNERABLE POPULATIONS

Unspecified

Characteristics of the Primary Clinical Component

INCIDENCE/PREVALENCE

Unspecified

ASSOCIATION WITH VULNERABLE POPULATIONS

Unspecified

BURDEN OF ILLNESS

Unspecified

UTILIZATION

Unspecified

COSTS

Unspecified

Institute of Medicine National Healthcare Quality Report Categories

IOM CARE NEED

Getting Better

IOM DOMAIN

Effectiveness
Safety

Data Collection for the Measure

CASE FINDING

Users of care only

DESCRIPTION OF CASE FINDING

Patients receiving neuraxial blockade as part of their acute pain management, during the time period under study

DENOMINATOR SAMPLING FRAME

Patients associated with provider

DENOMINATOR INCLUSIONS/EXCLUSIONS

Inclusions
Total number of patients receiving neuraxial blockade as part of their acute pain management, during the time period under study

Exclusions
Unspecified

RELATIONSHIP OF DENOMINATOR TO NUMERATOR

All cases in the denominator are equally eligible to appear in the numerator

DENOMINATOR (INDEX) EVENT

Therapeutic Intervention

DENOMINATOR TIME WINDOW

Time window brackets index event

NUMERATOR INCLUSIONS/EXCLUSIONS

Inclusions
Total number of patients developing an epidural abscess, or epidural haematoma following neuraxial blockade, during the time period under study

Exclusions
Unspecified

MEASURE RESULTS UNDER CONTROL OF HEALTH CARE PROFESSIONALS, ORGANIZATIONS AND/OR POLICYMAKERS

The measure results are somewhat or substantially under the control of the health care professionals, organizations and/or policymakers to whom the measure applies.

NUMERATOR TIME WINDOW

Episode of care

DATA SOURCE

Administrative data
Medical record

LEVEL OF DETERMINATION OF QUALITY

Not Individual Case

OUTCOME TYPE

Adverse Outcome

PRE-EXISTING INSTRUMENT USED

Unspecified

Computation of the Measure

SCORING

Rate

INTERPRETATION OF SCORE

Better quality is associated with a lower score

ALLOWANCE FOR PATIENT FACTORS

Unspecified

STANDARD OF COMPARISON

External comparison at a point in time
External comparison of time trends
Internal time comparison

Evaluation of Measure Properties

EXTENT OF MEASURE TESTING

Unspecified

Identifying Information

ORIGINAL TITLE

Indicator area 5: management of acute pain CI 5.10.

MEASURE COLLECTION

MEASURE SET NAME

DEVELOPER

Australian Council on Healthcare Standards

FUNDING SOURCE(S)

Funding is direct Australian Council on Healthcare Standards (ACHS) funding sourced through our membership. ACHS does not receive external funding from the government or other sources.

COMPOSITION OF THE GROUP THAT DEVELOPED THE MEASURE

Our terms of reference dictate the composition of the working parties that develop our indicators and include the following:

  • Two Clinicians -- nominated by the relevant specialty college/association/society, one nominated to be the chair of the working party
  • Private Hospital Representative -- nominated by the Australian Private Hospital Association
  • Consumer Representative -- nominated by the Consumer Health Forum of Australia
  • Coding Representative -- nominated by the National Centre for Clinical classification on Health
  • Quality Health New Zealand, nominated by QHNZ (if applicable)
  • Epidemiological/Clinical Research Representative, Director of Health Services Research Group, University of Newcastle
  • Australian Council on Healthcare Standards (ACHS) Representatives -- Clinical Director, Coordinator, Administrative Assistant
  • Other Expert Stakeholders, as required

FINANCIAL DISCLOSURES/OTHER POTENTIAL CONFLICTS OF INTEREST

None

ADAPTATION

Measure was not adapted from another source.

RELEASE DATE

1996 Sep

REVISION DATE

2007 Dec

MEASURE STATUS

This is the current release of the measure.

SOURCE(S)

  • Australian Council on Healthcare Standards (ACHS). ACHS clinical indicator users' manual 2008. ULTIMO NSW: Australian Council on Healthcare Standards (ACHS); 2007 Dec. 776 p.

MEASURE AVAILABILITY

COMPANION DOCUMENTS

NQMC STATUS

This NQMC summary was completed by ECRI Institute on April 4, 2008.

COPYRIGHT STATEMENT

This NQMC summary is based on the original measure, which is subject to the measure developer's copyright restrictions. This work is copyright. Apart from any use as permitted under the Copyright Act 1968, no part may be reproduced by any process without written permission from The Australian Council on Healthcare Standards (ACHS).

Disclaimer

NQMC DISCLAIMER